Evidence map›Paper›PMID 42250885›Full record

ArticleJournal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance2026

Circumferential strain recovery after human cardiomyocyte transplantation in minipigs using a novel frequency-based method for myocardial tagging quantification.

Anna V Naumova, Kenta Nakamura, Silvia Marchiano, Lauren E Neidig, Leslie P Blakely, Hiroshi Tsuchida, Charles E Murry, William S Kerwin

Abstract read
In one paragraph

Article in Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Anna V NaumovaDepartment of Radiology, University of Washington, Seattle, Washington, USA. Electronic address: nav@uw.edu.
Kenta NakamuraInstitute for Stem Cells and Regenerative Medicine, University of Washington, Seattle, Washington, USA; Department of Medicine, Division of Cardiology, University of Washington, Seattle, Washington, USA.
Silvia MarchianoInstitute for Stem Cells and Regenerative Medicine, University of Washington, Seattle, Washington, USA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA; Center of Cardiovascular Biology, University of Washington, Seattle, Washington, USA.
Lauren E NeidigInstitute for Stem Cells and Regenerative Medicine, University of Washington, Seattle, Washington, USA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA; Center of Cardiovascular Biology, University of Washington, Seattle, Washington, USA.
Leslie P BlakelyInstitute for Stem Cells and Regenerative Medicine, University of Washington, Seattle, Washington, USA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA; Center of Cardiovascular Biology, University of Washington, Seattle, Washington, USA; Department of Comparative Medicine, University of Washington, Seattle, Washington, USA.
Hiroshi TsuchidaInstitute for Stem Cells and Regenerative Medicine, University of Washington, Seattle, Washington, USA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA; Center of Cardiovascular Biology, University of Washington, Seattle, Washington, USA; Department of Comparative Medicine, University of Washington, Seattle, Washington, USA; Currently at Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Charles E MurryInstitute for Stem Cells and Regenerative Medicine, University of Washington, Seattle, Washington, USA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA; Center of Cardiovascular Biology, University of Washington, Seattle, Washington, USA; Currently at Department of Stem Cell Biology and Regenerative Medicine, University of South California, Los Angeles, California, USA.
William S KerwinDepartment of Radiology, University of Washington, Seattle, Washington, USA; Currently at Altius Institute for Biomedical Sciences, Seattle, Washington, USA.

Funding

Metabolic and Transcriptional Reprogramming of Cardiac MaturationR01HL148081 · NHLBI · UNIVERSITY OF WASHINGTON · PI MURRY, CHARLES E · 2021 to 2024
$2.5M
NHLBI NIH HHS R01 HL148081
6 · The paper itself

Abstract

backgroundTransplantation of human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) is a promising new method for heart remuscularization after infarction. We hypothesized that hPSC-CMs affect heart function by improving local contractility in the infarcted zones. However, there is a need for a precise noninvasive assessment of regional contractile function in the infarcted segments.

methodsWe describe here a novel approach for rapid and robust quantification of myocardial end-systolic circumferential strain (CS). Linear tags are placed in 60-degree pattern offsets and analyzed via optimized post-processing based on local Fourier transformation of standardized American Heart Association (AHA) myocardial segmentation. This method has been implemented for the first time to evaluate transendocardial hPSC-CMs transplantation in a minipig model of myocardial infarction. Validation of the new frequency-based calculation of myocardial strain was done using two independent approaches as follows: (1) a tag tracking, and (2) feature tracking technique.

resultsIn the cell-treated hearts (n=4), mean end-systolic CS in the infarcted segments (anterior and anteroseptal areas combined) at the mid-wall region decreased from -6.69 ± 1.56% (pre-MI) to -1.13 ± 1.96% at 2 weeks post-MI (pre-treatment), with subsequent improvement to -4.00 ± 0.76% by 8 weeks after cell transplantation. Conversely, CS in the infarcted segments in vehicle-control group (n=5) decreased from -5.18 ± 0.97% (pre-MI) to -1.39 ± 1.23% at 2 weeks post-MI and worsened further to 0.33 ± 1.93% by 8 weeks post-vehicle. There was no improvement in the global ejection fraction in the cell-treated group in comparison with control. It was a high correlation of the new method of myocardial strain calculation with the standard tag tracking approach and feature tracking strain analysis across the experimental conditions (normal heart, infarcted, cell/vehicle treated).

conclusionsA novel frequency-based technique for assessment of local circumferential strain does not require specialized acquisition protocols, access to k-space data, nor highly optimized reconstruction algorithms or commercial software. It can quickly and precisely assess regional myocardial injury and recovery. Our findings support our hypothesis that transplantation of hPSC-CMs improves regional myocardial strain in infarcted minipig hearts.

Indexed as

cell transplantationlarge animal modelsmyocardial infarctionmyocardial strainquantitative measurements

Identifiers

PMID42250885
PMCPMC13311266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.